Inventor · disambiguated record
Leonid Gitlin
Also filed as: GITLIN LEONID
6 granted patents·22 pending applications·6 citations·filing 2017–2025
75Inventor score
Top patents by PatentIndex Score
28 records- 0189US12109257B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Oct 8, 2024·1 cites·20 claims
- 0289US11591619B2Modified adenovirusesGRITSTONE BIO INC·Filed 2021·Granted Feb 28, 2023·1 cites·41 claims
- 0388US11771747B2Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2022·Granted Oct 3, 2023·2 cites·23 claims
- 0488US11510973B2Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Nov 29, 2022·1 cites·57 claims
- 0583US2025249084A1Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0680US11504421B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2018·Granted Nov 22, 2022·1 cites·30 claims
- 0779US12098383B2Modified adenovirusesGRITSTONE BIO INC·Filed 2023·Granted Sep 24, 2024·0 cites·35 claims
- 0879US2025236884A1Modified adenovirusesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0971US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1069US2025025544A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1169US2023128001A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1268US2025270589A1Viral delivery of neoantigensSEATTLE PROJECT CORP·Filed 2025·Application pending·0 cites
- 1367US2024285739A1Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1463US2024238412A1Pancoronavirus vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1562US2022265812A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 1659US2025121052A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1759US2023310563A1Antigen-encoding cassettesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1858US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1958US2023303614A1Capping compounds, compositions and methods of use thereofGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2057US2023047979A1Durable vaccinationGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2157US2024050550A1Infectious disease antigens and vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2257US2023330215A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2356US2021213122A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2453US2024093235A1Homologous adenoviral vaccinationGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 2551US2022125919A1Alphavirus neoantigen vectors and interferon inhibitorsGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 2648US2020010849A1Viral delivery of neoantigensGRITSTONE ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 2744US2025276049A1Egfr vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 2842US2025269002A1Cta vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →